Board of Directors
The N2 Board of Directors consists of 11 individuals representing the different stakeholders within N2 membership.
Jim Pankovich
Chair
Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.
Rachel Syme
Vice Chair
Assistant Director, Institute of Cancer Research, CIHR
Patrick Clifford
Treasurer
N2 Board Member
N2 Treasurer
Erin Cherban
Secretary
Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)
Linda Bennett
Board Member
Project Manager, Marvelle Koffler Breast Centre Research Program
Daniela M. Bianco
Board Member
Manager, Research Development & Relations, Hamilton Health Sciences
Kathy Brodeur-Robb
Board Member
Executive Director C-17 Council
Lisa Johnston
Board Member
Clinical Research Facilitator, Ottawa Hospital Research Institute (OHRI)
Jennifer Li
Board Member
Quality Manager, Cancer Clinical Research Unit, Princess Margaret Cancer Centre – University Health Network
Tammy Mah-Fraser
Board Member
Director, Platform Operations – Alberta Innovates – Health Solutions
Janette Panhuis
Board Member
Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University